In order to best protect the health and well-being of our University community, and in accordance with the latest public health guidance, we are requiring the COVID-19 vaccine for all members of our University community. More than 500 colleges and universities across the country – including many of our peer institutions in Connecticut – have implemented this policy to mitigate the impact of COVID-19 on their campuses.
Fully vaccinated members of our University community will be able to immerse themselves in work and learning environments featuring pre-pandemics norms for class formats, student life, and other staples of the Charger experience.
Biomedical Engineering Professor Reflects on the Success of Recent Graduate
Kagya Amoako, Ph.D. introduces us to Yaw Ansong Jr. ’19 M.S., who since graduating from the University has created a medical diagnostics company that has collaborated with scientists at Yale and Duke. Soon, he will begin pursuing a Ph.D. at UC Berkeley.
April 29, 2020
By Kagya Amoako, Ph.D.
Yaw Ansong Jr. ’19 M.S. admits he is amazed at how his career has progressed since he graduated from the University of New Haven’s graduate program in biomedical engineering (BME). Originally from Ghana, Yaw practiced medicine in his native country before moving to the U.S. to pursue a graduate degree at the University of New Haven.
“I’ve always loved engineering and technology, and I always knew I wanted to combine my medical knowledge with engineering,” he said. “I didn’t know how I would achieve that until I came to the University of New Haven.
I was not surprised to learn that he was accepted at some of the best institutions in the country. His success is a testament to the University’s graduate program in biomedical engineering’s focus on students and research. His story is not unique in our program.
The skills Yaw developed came in handy when he graduated from the University. While his colleagues were job hunting and receiving offers, he spent time developing his new venture, KovaDx, a medical diagnostics company aiming to fix the health disparity faced by people with sickle cell disease, which was funded through grants.
Working to develop a device that combines 3D phase images with deep learning to make the diagnosis of blood morphological diseases cheaper and easier to perform, the company has research partnerships and collaborations with scientists at Yale and Duke University. It has also been selected for awards and grants including Connecticut Innovation’s biopipeline grant, the Rothberg Prototype Fund Award, and the Rita Wilson Prize Fund from Yale.
‘If there’s anything life has taught me, it's that the right education and the right mentorship opportunities matter,” said Yaw. “I’ll never forget the experiences I had at the University of New Haven.”
Dr. Kagya Amoako is an associate professor of biomedical engineering at the University of New Haven. He is also coordinator of the graduate program in biomedical engineering and director of the University’s Biomaterials and Medical Device Innovation Laboratory.